This HTML5 document contains 202 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36021497
rdf:type
wikibase:Item
schema:description
2007年论文 2007年の論文 bài báo khoa học vědecký článek artigo científico vetenskaplig artikel 2007年论文 vitenskapelig artikkel наукова стаття, опублікована в березні 2007 mokslinis straipsnis artikull shkencor 2007年論文 գիտական հոդված vitskapeleg artikkel scientific article bilimsel makale научни чланак scienca artikolo artículo científico publicado en 2007 επιστημονικό άρθρο 2007年論文 научная статья мақолаи илмӣ article científic artigo científico (publicado na 2007) სამეცნიერო სტატია 2007年论文 2007年论文 2007 nî lūn-bûn articolo scientifico مقالهٔ علمی 2007년 논문 article scientific 2007年论文 מאמר מדעי wissenschaftlicher Artikel vedecký článok ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2007年論文 artykuł naukowy tudományos cikk article scientifique (publié 2007) مقالة علمية мақолаи илмӣ 2007年論文 artikulong pang-agham naučni članak научна статия articol științific 2007年論文 บทความทางวิทยาศาสตร์ artículu científicu espublizáu en 2007 سائنسی مضمون videnskabelig artikel (udgivet 2007) 2007年论文 научни чланак tieteellinen artikkeli teaduslik artikkel wetenschappelijk artikel artigo científico (publicado na 2007)
p:P577
wds:Q36021497-32540FBF-8DE4-4057-90ED-332BE86D8574
wdt:P577
2007-03-12T00:00:00Z
p:P407
wds:Q36021497-97FCB3AC-6F4E-465A-B289-C92D2B81DB42
wdt:P407
wd:Q1860
p:P2860
wds:Q36021497-03C080C0-AA00-456F-ADDE-ADBF1F4535C9 wds:Q36021497-068CF9A7-DB2A-4BB4-81A6-4D9D70244696 wds:Q36021497-1160072C-8E50-4A51-B383-7375BE3F74DD wds:Q36021497-150667AB-B9BF-40B0-BA61-87978501B93A wds:Q36021497-166EF2BD-D212-4A61-9848-9765D8F6834B wds:Q36021497-02622800-699A-4635-B124-BA678691B716 wds:Q36021497-EBCEB734-A930-4B52-8F61-941D2344B8A2 wds:Q36021497-EEDB61AE-CC35-4932-949A-5705D6C244F4 wds:Q36021497-FA8BF52F-F712-4099-AD16-E2FBB2557D54 wds:Q36021497-FF2346E8-2B29-461A-B4E4-5320622CAD5B wds:Q36021497-B83521A8-81D9-4216-97D1-C07084B7BBDF wds:Q36021497-BB18C4A7-3188-418F-B476-5A3A072EEC0C wds:Q36021497-C0A60D8C-AAF3-4277-8440-48744594D704 wds:Q36021497-98174A7D-4A68-4016-9A94-61BDEAF37D2A wds:Q36021497-9E22149C-2F61-49C9-BC5F-6A0F7EFB74F3 wds:Q36021497-A2307507-0EC7-489C-9C0C-B01F1FBBC6F8 wds:Q36021497-A8454A6B-2056-49B4-8DAD-5A31EBF5B35E wds:Q36021497-AC9A6496-9CC2-4D62-B630-519DCA34FAE3 wds:Q36021497-AD01A0AE-EED2-4B3B-A34B-DF0E5B2613DA wds:Q36021497-898CA920-F3CD-4BFD-AB5D-66579741BFF0 wds:Q36021497-8BF4BE75-C927-457C-86E8-D684651DBB5D wds:Q36021497-8CF7014D-7032-4F1B-ADC1-5F037E7B3F35 wds:Q36021497-94169680-88EC-41D9-A4EF-E0F9C71C201B wds:Q36021497-94E2116D-4A15-4B66-A337-AD26D4B5EAB0 wds:Q36021497-56B7D244-0363-4E4E-B5E9-5A12D790D5E1 wds:Q36021497-5C945348-F1C0-4016-ADF0-BA97F5107651 wds:Q36021497-67F3690F-2B96-4E36-AB21-499FDCDF3AC1 wds:Q36021497-74474853-F4E6-49D9-92CF-E22288F3DF8C wds:Q36021497-84722C9F-5A33-40E0-B567-DDE857CDA43A wds:Q36021497-3A240775-A71E-496C-A8BE-D435435B4175 wds:Q36021497-40E0A019-5242-4E2C-A61A-6D742D2E0C86 wds:Q36021497-42163DB4-97B6-43EE-B631-F4D7AC9E0C73 wds:Q36021497-45D9EBF4-166D-4D4B-81B9-2E39F05B5FDF wds:Q36021497-4C4C3D73-B120-436F-A708-CAE06FF740AC wds:Q36021497-50478C0A-9DFC-4DE5-9130-E1DF463DBE48 wds:Q36021497-50F69520-5BB1-457B-84AB-BE940043CF46 wds:Q36021497-1D2C4590-67C1-464E-885F-EC3B5921180E wds:Q36021497-1DE6ABF2-0653-4D69-92BD-1A3B12D95176 wds:Q36021497-1F6C1177-4B7F-475D-8AE3-8BE13146C474 wds:Q36021497-30D00621-D4F9-4592-8B89-E530CDA2E4AF
wdt:P2860
wd:Q53954128 wd:Q40765134 wd:Q36619817 wd:Q41471642 wd:Q40341084 wd:Q41091588 wd:Q40852678 wd:Q29617742 wd:Q73705884 wd:Q40676293 wd:Q40624883 wd:Q40362219 wd:Q74355738 wd:Q36210926 wd:Q41109783 wd:Q40299109 wd:Q39711754 wd:Q82063244 wd:Q34661616 wd:Q42142458 wd:Q54380012 wd:Q52832264 wd:Q24312129 wd:Q40558191 wd:Q35567287 wd:Q22008574 wd:Q60230381 wd:Q38337454 wd:Q41324683 wd:Q41173812 wd:Q54189587 wd:Q38411404 wd:Q40223954 wd:Q54403870 wd:Q42478417 wd:Q40550198 wd:Q28201937 wd:Q42819928 wd:Q29616803 wd:Q36263117
p:P2093
wds:Q36021497-097CFB0F-0C77-4D48-A226-6A9DBDEF85F1 wds:Q36021497-976D4CB3-43C7-45E9-B3A6-97C7F421FC41 wds:Q36021497-F0DA553E-30A4-432E-B40F-8BE0F77DD048 wds:Q36021497-D176F0BD-6A13-4EAB-8A6B-8073B64C033F wds:Q36021497-D24F5C43-684A-4039-B9FE-4BF9E574A841
wdt:P2093
L Elbling R Dornetshuber M Micksche W Körner P Chiba
rdfs:label
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
skos:prefLabel
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
schema:name
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
p:P50
wds:Q36021497-A5BCBFAD-2F19-4F12-843B-59791EC60A9D wds:Q36021497-BF2E2E86-A944-4ED7-AD25-C677CC4DF3EB wds:Q36021497-BE498BD0-FEE1-478A-850F-CFCD0D65DFFA wds:Q36021497-1FCEE154-D755-466D-86B9-C60D26C6B909 wds:Q36021497-541F545F-B9EB-463A-8F8F-01B9977C0954 wds:Q36021497-80BE79EC-61B4-4180-B9B2-9F948B5BC89D
wdt:P50
wd:Q42173445 wd:Q39186773 wd:Q58330483 wd:Q39031767 wd:Q38800373 wd:Q38800395
p:P1476
wds:Q36021497-CE39CA06-6511-4B8D-BA66-571F6EBBADDE
wdt:P1476
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)
p:P304
wds:Q36021497-1793A113-C355-491C-9831-A45EC8702C1F
wdt:P304
1873-1886
p:P31
wds:Q36021497-AF3A9E0C-89E4-49E0-A2EF-47E2F60555E3
wdt:P31
wd:Q13442814
p:P921
wds:Q36021497-58540929-EBD8-4839-B3A4-BA7958EA1C8C wds:Q36021497-C63265E8-FDEE-4946-B80B-DC95975106BA
wdt:P921
wd:Q643839 wd:Q1801
p:P698
wds:Q36021497-D27C71F7-E88C-490A-B436-9B42FCE75BEA
wdtn:P698
n12:17445775
wdt:P698
17445775
p:P1433
wds:Q36021497-09BC4D9E-8C44-4C9D-A82D-5F86D3C1DD6F
wdt:P1433
wd:Q864229
p:P433
wds:Q36021497-304E1A20-87D9-4938-A18D-5970074EFFD7
p:P478
wds:Q36021497-69574C7E-1548-4E0B-9566-80DF54ABDFD0
wdt:P433
12
wdt:P478
73
p:P356
wds:Q36021497-9F3A148A-F6B3-48F8-B370-D33E5CA0E9C4
wdtn:P356
n9:J.BCP.2007.03.002
wdt:P356
10.1016/J.BCP.2007.03.002
p:P5875
wds:Q36021497-2889B657-0301-41E8-8FD7-2F6A65C1FDDD
wdt:P5875
6382585
p:P932
wds:Q36021497-8B95DBA8-B44D-4F78-849B-D324C52F9273
wdt:P932
3371634